Clinical Trials Logo

Clinical Trial Summary

In this study the investigators observe the investigation, whether the new method for Boost-Irradiation with the Intrabeam Device of Zeiss Germany influences local recurrence, acute and late effects of Radiotherapy, overall survival, quality of life and cosmesis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Adverse Effect of Radiation Therapy

NCT number NCT02114086
Study type Observational
Source Kantonsspital Münsterlingen
Contact
Status Active, not recruiting
Phase
Start date January 2013
Completion date August 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT02586727 - Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy Phase 2
Recruiting NCT02052102 - Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart Phase 2
Unknown status NCT01863420 - The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer Phase 2
Completed NCT02922244 - Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients N/A
Completed NCT02406183 - Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma Phase 1
Completed NCT01621880 - Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma Phase 2
Enrolling by invitation NCT02066974 - Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy N/A
Completed NCT02142907 - Evaluation of Two Boost Radiation Schedules in Post Lumpectomy Early Stage Carcinoma Breast
Not yet recruiting NCT04127760 - Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total Resection N/A
Recruiting NCT04553510 - Treatment of Bevacizumab Followed by Steroid in RN Phase 2
Completed NCT03359187 - Prevention of Mucositis in Patients With Head and Neck Cancer Treated With Radiotherapy N/A
Completed NCT00780312 - Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer Phase 2